An updated risk score can help predict possible contrast-associated acute kidney injury (CA-AKI) among patients undergoing percutaneous coronary intervention (PCI), according to Mount Sinai Heart researchers, led by Roxana Mehran, MD, Director of Interventional Cardiovascular Research and Clinical Trials at the Icahn School of Medicine at Mount Sinai. The team said the simple and unique assessment tool can enhance management of patients at high risk of CA-AKI before, during, and after PCI, and improve their prognosis following the procedure.
